- Report
- February 2021
- 360 Pages
United States
From €2308EUR$2,400USD£1,980GBP
- Report
- January 2021
- 148 Pages
China, Global
From €3000EUR$3,342USD£2,664GBP
- Report
- May 2024
- 50 Pages
Global
From €2548EUR$2,650USD£2,186GBP
Zidovudine, also known as AZT, is an antiretroviral drug used to treat HIV/AIDS and other immune disorders. It works by blocking the action of reverse transcriptase, an enzyme that helps HIV replicate. Zidovudine is usually taken in combination with other antiretroviral drugs to reduce the risk of drug resistance. It is also used to reduce the risk of mother-to-child transmission of HIV.
Zidovudine is available in both oral and intravenous forms. It is usually taken once or twice daily, depending on the patient's condition. Common side effects include nausea, vomiting, headache, and fatigue. More serious side effects include anemia, liver damage, and pancreatitis.
The zidovudine market is highly competitive, with many companies offering generic versions of the drug. Companies such as Cipla, Mylan, and Teva Pharmaceuticals are some of the major players in the market. Other companies include Aurobindo Pharma, Sun Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more